Immunic, Inc. (IMUX) Free cash flow 2016–2025
Immunic, Inc. (IMUX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$86.0MFY2025 · since FY2016: -$36.3M → -$86.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$86.0M | -1.1% |
| FY2024 | -$85.0M | -19.5% |
| FY2023 | -$71.2M | -9.1% |
| FY2022 | -$65.3M | +21.7% |
| FY2021 | -$83.3M | -80.0% |
| FY2020 | -$46.3M | -61.8% |
| FY2019 | -$28.6M | -192.7% |
| FY2018 | -$9.8M | +76.2% |
| FY2017 | -$41.1M | -13.1% |
| FY2016 | -$36.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice